Medical Marijuana Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome Cannabis Investing News
Protext Mobility Discusses Potential for Phytofare to treat Type II Diabetes Pharmaceutical Investing
Beleave and Ryerson University Continue Research and Development of Industrial Processes Pharmaceutical Investing
BrainStorm Cell Therapeutics appoints new Chief Operating Officer and Chief Medical Officer Genetics Investing
Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra Pharmaceutical Investing
Stellar Biotechnologies enters exclusive agreement with Amaran Biotechnology Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
